Publications by authors named "Pankti D Reid"

Claim this Profile
C
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Anne R Bass, Noha Abdel-Wahab, Pankti D Reid, Jeffrey A Sparks, Cassandra Calabrese

Ann Rheum Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socially optimal pandemic drug dosing.
Garth W Strohbehn, William F Parker, Pankti D Reid, Walid F Gellad

Lancet Glob Health· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.

JAMA· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Therapy Toxicities-Reply.
Adam S Cifu, Anne R Bass, Pankti D Reid

JAMA· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.
Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, Jonathan A Trujillo, Jovian Yu, Pankti D Reid

Clin Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy.
Pankti D Reid, Adam S Cifu, Anne R Bass

JAMA· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19.
Garth W Strohbehn, Pankti D Reid, Mark J Ratain

Clin Pharmacol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19.
Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, Jonathan A Trujillo, Jovian Yu, Pankti D Reid

medRxiv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis